Showing results (41-50 of 3,466) with videos related to
Sort By:
Pageof 347
The American Journal of Medicine|March 1, 1985
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survivalD C Ihde, M J Matthews, R W Makuch, et al.Radiology|February 1, 1983
Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinomaR M Levenson, B J Sauerbrunn, H R Bates, et al.Cancer Treatment Reports|September 1, 1981
Phase II trial of cisplatin in small cell carcinoma of the lungR M Levenson, D C Ihde, M S Huberman, et al.Cancer Research|April 1, 1982
Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humansR L Schilsky, J A Kelley, D C Ihde, et al.Cancer|March 15, 1980
Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide: methods of documenting tumor response and progressionD C Ihde, P A Bunn, M H Cohen, et al.Cancer Treatment Reports|September 1, 1978
5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancerP A Bunn, J L Nugent, D C Ihde, et al.JAMA|November 27, 1981
Perirectal infections in patients with small cell lung cancerM F Earle, B E Fossieck, M H Cohen, et al.Archives of Internal Medicine|February 8, 1993
Application of an algorithm for staging small-cell lung cancer can save one third of the initial evaluation costsG E Richardson, D J Venzon, M Edison, et al.Journal of Cellular Biochemistry. Supplement|January 1, 1996
MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancerB E Johnson, E Russell, A M Simmons, et al.American Journal of Clinical Oncology|April 1, 1983
Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lungJ Z Fuks, J Aisner, D A Van Echo, et al.Pageof 347